Clinical Documentation Physician Compensation Incentives
NCT ID: NCT05527977
Last Updated: 2024-01-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2022-09-26
2023-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators' proposed project will use physician compensation incentives to improve documentation of clinically significant details for six common diagnoses in outpatient general internal medicine. The investigators will choose clinically significant details which more accurately represent patient complexity, improve the diagnostic process, and have potential to improve patient outcomes. To determine whether compensation incentives improve documentation of clinically significant details, the investigators will compare physicians' baseline documentation to incentivized documentation. The purpose of the investigators' project is to improve communication of clinically significant diagnostic information among physicians, thereby reducing suboptimal treatment plans, overuse, medical error, and cognitive burden upon physicians.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Enhancing Empathy in Medical Communication Through Perspective-Taking
NCT00861991
Understanding Physician Work Motivation
NCT02263521
Contacting Authors to Retrieve Individual Patient Data
NCT02569411
Healthcare Professionals' Attitude Towards Clinical Research in the United Arab Emirates
NCT06531616
Financial Incentives for Medication Adherence
NCT01678183
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Approach: To determine whether compensation incentives improve documentation of clinically significant details, the investigators will compare physicians' baseline documentation (during a 6-week run-in period) to incentivized documentation (a 3-month period when physicians will receive compensation incentives for their clinical documentation). Two research assistants will perform retrospective chart review and audits of office visit progress notes. Notes will be scored for whether documentation includes pre-specified clinically significant information. For example, if a patient has had a Deep Vein Thrombosis (DVT), the investigators would assess whether the month of onset of the DVT and duration of anticoagulation therapy was documented in the note. The investigators anticipate that compensation incentives will improve physicians' clinical documentation of clinically significant medical details. The investigators' results will be reported in aggregate at the physician-level.
Participation: 30-35 physicians will be invited to participate in both the incentives program and analysis comparing baseline performance to incentivized performance. If a physician opts out of the analysis, that participant will not be eligible for compensation incentives. The investigators chose a sample of 30-35 physicians so that the study has enough power to detect a significant difference in performance in clinical documentation during the incentivized period compared to baseline.
Risks to patients: The investigators will use patient-level data as covariates in the analysis. The investigators' analysis will occur in a similar fashion as other retrospective studies, whereby patient-level information will be used from individual office visits in the analysis. Patient-level information will be de-identified as quickly as possible and precautions will be made to keep patient and physician-level data secure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SEQUENTIAL
The intevestigators will compare baseline documentation (Arm #1) with incentivized documentation (Arm #2)
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Baseline Period
Run-in non-incentivized period for all participants.
No interventions assigned to this group
Incentivized Period
3 month period during which time clinicians will receive compensation incentives for their performance in the program to improve clinical documentation.
Compensation Incentives to improve Clinical Documentation
The investigators have identified six Diagnoses of Interest for the initiative. For each Diagnosis of Interest, the investigators have specified a series of clinically significant diagnostic details. Each physician will receive a compensation bonus from a pool of $20,000 based on the absolute number of times that he or she appropriately documented a Diagnosis of Interest.
The investigators will use SQL Server Management Studio 18.0 to create an initial dataset using ICD-10 codes from office visits during which a Diagnosis of Interest was addressed. The investigators will compare documentation during the 12-week against a 6-week period prior to the intervention. The 6-week period will not be used to determine compensation bonuses. Two blinded research assistants will review H\&P's and progress notes from extracted visits to tabulate the number of times that clinical documentation met expectations.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Compensation Incentives to improve Clinical Documentation
The investigators have identified six Diagnoses of Interest for the initiative. For each Diagnosis of Interest, the investigators have specified a series of clinically significant diagnostic details. Each physician will receive a compensation bonus from a pool of $20,000 based on the absolute number of times that he or she appropriately documented a Diagnosis of Interest.
The investigators will use SQL Server Management Studio 18.0 to create an initial dataset using ICD-10 codes from office visits during which a Diagnosis of Interest was addressed. The investigators will compare documentation during the 12-week against a 6-week period prior to the intervention. The 6-week period will not be used to determine compensation bonuses. Two blinded research assistants will review H\&P's and progress notes from extracted visits to tabulate the number of times that clinical documentation met expectations.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical FTE \>40%
Exclusion Criteria
Equitable considerations include: Enrolling all clinicians (MD/DO, PA, NP) at each practice. Physicians with \<40% FTE are expected to be eligible to earn low amounts of income from the program (estimated around less than $300 before taxes over 3-month period), hence the investigators will exclude them due to poor motivating force of this total incentive and adverse impacts on the statistical analysis.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rush University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David S. Burstein
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David S Burstein, MD MS
Role: PRINCIPAL_INVESTIGATOR
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rush University Medical Center
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22060905-IRB01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.